Iodide

Iodide

SCHEMBL5178933

C[N+](C)(Cc1ccc(NC(=O)C2=Cc3c(ccc4ccccc34)OC2)cc1)C1CCCCC1.[I-]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CCR2 P41597 9/20 0.53
▸ CCR5 P51681 10/20 0.45
▸ CXCR5 P32302 1/20 0.43
▸ CXCR3 P49682 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13148338 0.99 CCR2 (0.53) CCR2CCR5CXCR5CXCR3
Hydrochloric Acid SCHEMBL2902553 0.98 CCR2 (0.53) CCR2CCR5CXCR5CXCR3
Iodide SCHEMBL17555094 0.92 CCR2 (0.63) CCR2CCR5CXCR5CXCR3
Iodide SCHEMBL17555149 0.92 CCR5 (0.54) CCR2CCR5CXCR5CXCR3
SCHEMBL13148336 0.91 CCR2 (0.64) CCR2CCR5CXCR5CXCR3
SCHEMBL13148339 0.91 CCR5 (0.53) CCR2CCR5CXCR5CXCR3
Hydrochloric Acid SCHEMBL313873 0.91 CCR2 (0.63) CCR2CCR5CXCR5CXCR3
Hydrochloric Acid SCHEMBL313568 0.90 CCR5 (0.53) CCR2CCR5CXCR5CXCR3
Iodide SCHEMBL17555123 0.84 CCR2 (0.54) CCR2CCR5
SCHEMBL13148315 0.83 CCR2 (0.55) CCR2CCR5CXCR5CXCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765803-B1 QUATERNARY SALT CCR2 ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2016-03-09 — — EP disclosed
EP-1765803-A1 QUATERNARY SALT CCR2 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2007-03-28 — — EP disclosed
WO-2006012135-A1 QUATERNARY SALT CCR2 ANTAGONISTS JANSSEN PHARMACEUTICA, N. V. (BE) 2006-02-02 — — WO disclosed
Send feedback